Another big deal on a day of mega-mergers: US drug company Pfizer is buying Mylan in an all-stock deal and combining the $10bn generic pharmaceutical company with its own off-patent branded and generic business.
The Pfizer business, called Upjohn, makes well known drugs such as Lipitor, Celebrex and Viagra, whose patents recently expired. Mylan, based just outside of Pittsburgh, is best known for its EpiPen, an injector used to halt life-threatening allergic reactions.
Pfizer shareholders will own 57% of the combined new company and Mylan shareholders will own 43% after the all-share merger.
The new company is expected to have revenues of $19-$20bn in 2020.
RE: Phase 2 outcomes paper part 114 Jul 2019 07:52
Daringinvestor - That was really a great read and I appreicate the effort that you put in to .
Although I don't totally understand the figures for theEF Score. For example the milds got a score of 17 to 25...out of what per 100 per 1000. maybe I am just being dense (not had much coffee this morning yet and a bit hungover :-) ).